chr22-46112885-C-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The XM_047441694.1(LOC124905135):c.*8296C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.375 in 487,820 control chromosomes in the GnomAD database, including 41,229 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.46 ( 20036 hom., cov: 33)
Exomes 𝑓: 0.34 ( 21193 hom. )
Consequence
LOC124905135
XM_047441694.1 3_prime_UTR
XM_047441694.1 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.359
Genes affected
MIRLET7BHG (HGNC:37189): (MIRLET7B host gene)
MIRLET7A3 (HGNC:31478): (microRNA let-7a-3) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.796 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOC124905135 | XM_047441694.1 | c.*8296C>G | 3_prime_UTR_variant | Exon 2 of 2 | XP_047297650.1 | |||
LOC124905135 | XM_047441695.1 | c.*8296C>G | 3_prime_UTR_variant | Exon 2 of 2 | XP_047297651.1 | |||
LOC124905135 | XM_047441696.1 | c.*8296C>G | 3_prime_UTR_variant | Exon 2 of 2 | XP_047297652.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.460 AC: 69887AN: 152000Hom.: 19995 Cov.: 33
GnomAD3 genomes
AF:
AC:
69887
AN:
152000
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.336 AC: 112743AN: 335702Hom.: 21193 Cov.: 0 AF XY: 0.332 AC XY: 62427AN XY: 188036
GnomAD4 exome
AF:
AC:
112743
AN:
335702
Hom.:
Cov.:
0
AF XY:
AC XY:
62427
AN XY:
188036
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.460 AC: 69970AN: 152118Hom.: 20036 Cov.: 33 AF XY: 0.453 AC XY: 33703AN XY: 74356
GnomAD4 genome
AF:
AC:
69970
AN:
152118
Hom.:
Cov.:
33
AF XY:
AC XY:
33703
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
724
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at